1. Home
  2. GROV vs CALC Comparison

GROV vs CALC Comparison

Compare GROV & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.24

Market Cap

45.5M

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$5.33

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROV
CALC
Founded
2016
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.5M
88.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GROV
CALC
Price
$1.24
$5.33
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$1.60
$16.00
AVG Volume (30 Days)
42.1K
105.2K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,808,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.42
52 Week High
$1.95
$7.20

Technical Indicators

Market Signals
Indicator
GROV
CALC
Relative Strength Index (RSI) 51.78 51.20
Support Level $1.07 $5.55
Resistance Level $1.25 $7.20
Average True Range (ATR) 0.06 0.75
MACD 0.01 -0.11
Stochastic Oscillator 94.32 31.25

Price Performance

Historical Comparison
GROV
CALC

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: